Project description
Grape-based products to reduce antibiotics use in farm animals
Antibiotics are actually used more heavily in farm animals than in people. This is a major concern since antibiotic-resistant bacteria from livestock pose a deadly risk to people. The EU-funded NeoGiANT project will develop a new set of products – animal feed, treatment products, sperm extenders – based on natural extracts that can decrease the use of antibiotics in farm animals, substitute synthetic preservatives, and provide antimicrobial and antioxidant protection to livestock. These new products, which can even improve the health and welfare of animals, rely on the natural origin extract e-Vitis, obtained from Vitis vinifera, using grape marc from high-quality white wines as raw material.
Objective
NeoGiANT is an innovative action coordinated by the University of Santiago de Compostela (Spain). NeoGiANT aims at developing a new set of products (animal feed, treatment products, sperm extenders) able to decrease the use of antibiotics on farmed animals and substitute synthetic preservatives. These new products, based on natural extracts, using an advanced isolation technique, will not only avoid the growth of microorganisms but also improve the health and welfare of the animals increasing profitability.
The proposal is based on the use of biomass sources that can provide cost-effective, efficient and green solutions to obtain functional ingredients in sustainable circular economy production systems. The new products developed will be based on one extract of natural origin called e-Vitis (obtained from Vitis vinifera). e-Vitis is isolated using as raw material grape marc from the production of high quality white wines, that preserves, after the winemaking process, a significant load of bioactive compounds originally present in the grape. In order to obtain a multicomponent ready-to-use extract using green solvent extraction approaches NeoGiANT is going to apply an alternative methodology to conventional extraction, to disrupt the grape marc and extract the bioactive compounds. This innovative green technology is simple, the conditions required are mild (energy savings), and can be easily scaled-up.
The advanced properties of the natural extract will provide antimicrobial and antioxidant protection to the animals improving their performance and serving as a prophylactic treatment. The target products to be developed will be designed to control a large number of infectious diseases of paramount importance in animal production, both in livestock and aquaculture.
Moreover, the emergence of new antimicrobial resistances (AMR) will be reduced, and existing antimicrobial resistances will be better controlled.
Fields of science
- medical and health scienceshealth sciencesinfectious diseases
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- social scienceseconomics and businesseconomicssustainable economy
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
- agricultural sciencesanimal and dairy sciencedomestic animalsanimal husbandryanimal feed
Keywords
Programme(s)
Funding Scheme
IA - Innovation actionCoordinator
15782 Santiago De Compostela
Spain
See on map
Participants (20)
EH26 0PZ Penicuik
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
EH26 0PZ PENICUICK
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
02 532 Warszawa
See on map
621 00 Brno
See on map
2100 GODOLLO
See on map
14195 Berlin
See on map
4099-002 Porto
See on map
38200 SAN CRISTOBAL DE LA LAGUNA
See on map
28004 Madrid
See on map
370 05 Ceske Budejovice
See on map
C1425FQB Buenos Aires
See on map
28003 Madrid
See on map
2630 Aartselaar
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
15782 Santiago De Compostela
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28021 Madrid
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
9031 Drongen
See on map
36410 PORRINO
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
04005 ALMERIA
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
24007 LEON
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
50600 Ejea De Los Caballeros
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.